Tag: Diabetes: Type II
Metformin, Sitagliptin Prolong Normoglycemia Remission in DKA
Findings in African-American patients with new-onset diabetic ketoacidosis and severe hyperglycemia
Avoiding Dry-Cooked Foods May Help Protect Against T2DM
Researchers suggest steaming, poaching, and stewing for better health
Dapagliflozin Improves Insulin Sensitivity in Type 2 Diabetes
Decrease in basal glucose oxidation; increases in lipid oxidation, plasma ketone concentration
Δ9-Tetrahydrocannabivarin Beneficial in Type 2 Diabetes
THCV significantly decreases fasting plasma glucose, improves pancreatic β-cell function
CABG Plus Optimal Medical Therapy Best in T2DM and CAD
During long-term follow-up, CABG + OMT linked to reduction in composite of death, MI, stroke
Maintaining Body Weight Linked to Reduced Costs in T2DM
Increase in costs for patients who gain ≥5 percent of baseline weight; increase varies with mean HbA1C
Metformin Linked to Increased Risk of Acute Dialysis in T2DM
Metformin-associated one-year risk of acute dialysis increased by 50.3 per 100,000 individuals
Barrier-Specific Care Significantly Improves Glycemic Control
Implementation of barrier-specific care paths linked to significant reduction in glycated hemoglobin
Duodenal Mucosal Resurfacing Cuts HbA1c in T2DM
More potent glycemic effect seen among patients undergoing long duodenal segment ablation
Early Intensification of Tx Speeds Attainment of A1C Goals
Findings in patients with newly diagnosed type 2 diabetes who have failure of metformin monotherapy
